These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3056251)

  • 21. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
    Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro activity of moxifloxacin against fluoroquinolone-resistant strains of aerobic gram-negative bacilli and Enterococcus faecalis.
    Tankovic J; Bachoual R; Ouabdesselam S; Boudjadja A; Soussy CJ
    J Antimicrob Chemother; 1999 May; 43 Suppl B():19-23. PubMed ID: 10382871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates.
    Tavío MM; Vila J; Ruiz J; Ruiz J; Martín-Sánchez AM; Jiménez de Anta MT
    J Antimicrob Chemother; 1999 Dec; 44(6):735-42. PubMed ID: 10590273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
    Howard BM; Pinney RJ; Smith JT
    Microbios; 1994; 77(311):121-31. PubMed ID: 8152392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene.
    Kumagai Y; Kato JI; Hoshino K; Akasaka T; Sato K; Ikeda H
    Antimicrob Agents Chemother; 1996 Mar; 40(3):710-14. PubMed ID: 8851598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacin.
    Bedard J; Chamberland S; Wong S; Schollaardt T; Bryan LE
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1457-64. PubMed ID: 2510591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
    Chen CR; Malik M; Snyder M; Drlica K
    J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinolone-resistant Escherichia coli.
    Ito CA; Gales AC; Tognim MC; Munerato P; Dalla Costa LM
    Braz J Infect Dis; 2008 Feb; 12(1):5-9. PubMed ID: 18553006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cleavable-complex formation by wild-type and quinolone-resistant Streptococcus pneumoniae type II topoisomerases mediated by gemifloxacin and other fluoroquinolones.
    Yague G; Morris JE; Pan XS; Gould KA; Fisher LM
    Antimicrob Agents Chemother; 2002 Feb; 46(2):413-9. PubMed ID: 11796351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.
    Hirai K; Aoyama H; Suzue S; Irikura T; Iyobe S; Mitsuhashi S
    Antimicrob Agents Chemother; 1986 Aug; 30(2):248-53. PubMed ID: 3532944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limitations of plasmid complementation test for determination of quinolone resistance due to changes in the gyrase A protein and identification of conditional quinolone resistance locus.
    Soussy CJ; Wolfson JS; Ng EY; Hooper DC
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2588-92. PubMed ID: 8109921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.
    Hooper DC; Wolfson JS; Souza KS; Tung C; McHugh GL; Swartz MN
    Antimicrob Agents Chemother; 1986 Apr; 29(4):639-44. PubMed ID: 3010850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA.
    Masecar BL; Robillard NJ
    Antimicrob Agents Chemother; 1991 May; 35(5):898-902. PubMed ID: 1649573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro antimicrobial activities of new quinolone antibiotics against Mycoplasma pneumoniae].
    Gohara Y; Arai S; Kuwano K; Kawashima T; Matsu-Ura I
    Nihon Saikingaku Zasshi; 1992 Mar; 47(2):387-93. PubMed ID: 1318981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of action of lomefloxacin.
    Piddock LJ; Hall MC; Wise R
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1088-93. PubMed ID: 2168142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV.
    Breines DM; Ouabdesselam S; Ng EY; Tankovic J; Shah S; Soussy CJ; Hooper DC
    Antimicrob Agents Chemother; 1997 Jan; 41(1):175-9. PubMed ID: 8980775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of moxifloxacin on its target topoisomerases from Escherichia coli and Staphylococcus aureus.
    Schedletzky H; Wiedemann B; Heisig P
    J Antimicrob Chemother; 1999 May; 43 Suppl B():31-7. PubMed ID: 10382873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibacterial activity of a new tetracyclic quinolone, No. 5290, against norfloxacin- and ciprofloxacin-resistant strains of Staphylococcus aureus.
    Kotera Y; Inoue Y; Ohashi M; Ito K; Tsukamoto G
    Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2644-6. PubMed ID: 1666861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus.
    Takenouchi T; Tabata F; Iwata Y; Hanzawa H; Sugawara M; Ohya S
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1835-42. PubMed ID: 8843290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones.
    Cullen ME; Wyke AW; Kuroda R; Fisher LM
    Antimicrob Agents Chemother; 1989 Jun; 33(6):886-94. PubMed ID: 2548439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.